Holen Sie sich die Stockscreener-App
2.05
10.81%
0.20
Handel nachbörslich:
1.76
-0.29
-14.15%
Biocardia Inc Aktie (BCDA) Neueste Nachrichten
HC Wainwright Increases Earnings Estimates for BioCardia - Defense World
BioCardia’s (BCDA) “Buy” Rating Reiterated at HC Wainwright - Defense World
BioCardia Third Quarter 2024 Earnings: US$0.61 loss per share (vs US$1.79 loss in 3Q 2023) - Yahoo Finance
BioCardia stock plunges to 52-week low, touches $1.93 - Investing.com India
BioCardia stock plunges to 52-week low, touches $1.93 By Investing.com - Investing.com Nigeria
BioCardia, Inc. (NASDAQ:BCDA) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: BioCardia announces progress in heart therapy trials By Investing.com - Investing.com UK
BioCardia Inc (BCDA) Q3 2024 Earnings Call Highlights: Breakthro - GuruFocus.com
BioCardia Inc (BCDA) Q3 2024 Earnings Call Highlights: Breakthroughs and Challenges in Cardiac ... - Yahoo Finance
BioCardia Reports Q3 2024 Progress and Financials - TipRanks
BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results - The Manila Times
BioCardia Reports 35% Net Loss Improvement, Advances CardiAMP Trial Milestone | BCDA Stock News - StockTitan
BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024 - The Manila Times
Cell therapy weekly: support for commercialization of complex therapies - RegMedNet
BioCardia concludes pivotal heart failure trial - Investing.com
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure - The Manila Times
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.59% - MSN
Beating Heart Patch Market to Make Great Impact in Near Future by 2031 |BIOCARDIA, INC., Athersys, Inc - openPR
BioCardia Inc (BCDA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance
Wall Street SWOT: BioCardia stock rides wave of FDA and CMS support for heart therapy - Investing.com
BioCardia, Inc. (NASDAQ:BCDA) Short Interest Update - Defense World
Trading Day Triumph: Biodesix Inc (BDSX) Ends at 1.59, a -11.67 Surge/Plunge - The Dwinnex
A new trading data show BriaCell Therapeutics Corp (BCTX) is showing positive returns. - SETE News
Dawson James downgrades BioCardia Inc. (BCDA) stock to a Neutral - Knox Daily
Harmony Asset Management LLC Trims Stock Position in The Boeing Company (NYSE:BA) - Defense World
The Boeing Company (NYSE:BA) Shares Sold by Edge Capital Group LLC - Defense World
Beck Capital Management LLC Has $1.47 Million Stock Position in The Boeing Company (NYSE:BA) - Defense World
Summit Trail Advisors LLC Boosts Stock Holdings in The Boeing Company (NYSE:BA) - Defense World
The time has not yet come to remove your chips from the table: Biolife Solutions Inc (BLFS) - SETE News
Sei Investments Co. Acquires 11,092 Shares of The Boeing Company (NYSE:BA) - Defense World
Market Watch Highlights: Biodexa Pharmaceuticals Plc ADR (BDRX) Ends on an Downturn Note at 0.29 - The Dwinnex
Avoro Capital Advisors LLC Has $77.68 Million Stock Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Discovery Capital Management LLC CT Invests $2.47 Million in BioNTech SE (NASDAQ:BNTX) - MarketBeat
Barrow Hanley Mewhinney & Strauss LLC Boosts Position in Bancolombia S.A. (NYSE:CIB) - MarketBeat
Benjamin F. Edwards & Company Inc. Buys 317 Shares of The Boeing Company (NYSE:BA) - Defense World
Benjamin Edwards Inc. Decreases Stake in Bank of America Co. (NYSE:BAC) - MarketBeat
Inspire Investing LLC Reduces Stock Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Auxier Asset Management Decreases Stock Position in The Boeing Company (NYSE:BA) - Defense World
Comparing BioLargo (NASDAQ:BLGO) and Chemours (NYSE:CC) - Defense World
Sompo Asset Management Co. Ltd. Has $663,000 Stake in The Boeing Company (NYSE:BA) - Defense World
Benjamin Edwards Inc. Has $816,000 Position in The Boeing Company (NYSE:BA) - Defense World
BioLife Solutions (NASDAQ:BLFS) Trading Up 5.8% - Defense World
Bridges Investment Management Inc. Acquires New Position in Bank of America Co. (NYSE:BAC) - MarketBeat
Is Bank of America Corporation (BAC) the Best Affordable Stock To Buy Right Now? - Yahoo Finance
BANCO DO BRASIL/S (OTCMKTS:BDORY) Share Price Crosses Below 200-Day Moving Average of $5.38 - MarketBeat
Hollencrest Capital Management Boosts Holdings in The Boeing Company (NYSE:BA) - Defense World
Bank of America Corp. stock underperforms Friday when compared to competitors - MarketWatch
IPO News: Everything you need to know about BioAge Labs’ IPO - AlphaStreet
Builders FirstSource (NYSE:BLDR) Given New $198.00 Price Target at Bank of America - Defense World
DCF Advisers LLC Buys 250 Shares of The Boeing Company (NYSE:BA) - Defense World
Acadian Asset Management LLC Sells 107,112 Shares of BioNTech SE (NASDAQ:BNTX) - MarketBeat
BioCardia’s $7.2 Million Common Stock Offering - Global Legal Chronicle
Bank of America Corp. stock outperforms competitors on strong trading day - MarketWatch
The Boeing Company (NYSE:BA) Stock Holdings Lowered by Blair William & Co. IL - Defense World
The Boeing Company (NYSE:BA) Shares Bought by Garner Asset Management Corp - Defense World
BioCardia regains Nasdaq compliance, continues listing By Investing.com - Investing.com Canada
Sachin Tendulkar stock jumps 8% after it gets buy call for an upside of 20% - Trade Brains
FirstCry shares surge 7% after BofA, MS initiate coverage, see up to 27% upside scope - The Economic Times
Bank of America Declares Preferred Stock Dividends for Fourth Quarter 2024 - Quantisnow
BCDA’s Stochastic Averages Dip: Analyzing BioCardia Inc.’s Stock Performance - The InvestChronicle
BCDABioCardia, Inc. Latest Stock News & Market Updates - StockTitan
BioCardia regains Nasdaq compliance, continues listing - Investing.com
BioCardia Regains Full Compliance with Nasdaq Listing Requirements - StockTitan
BLFS (Biolife Solutions Inc) may reap gains as insiders became active recently - Knox Daily
BioCardia Inc. [BCDA] Investment Appeal on the Rise - Knox Daily
BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules - ForexTV.com
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):